Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy

Cigall Kadoch1, Diana C Hargreaves, Courtney Hodges

  • 1Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.

Nature Genetics
|May 7, 2013
PubMed

Insights

Mammalian SWI/SNF (mSWI/SNF) subunits act as tumor suppressors. Mutations in these chromatin-regulatory complexes are found in nearly 20% of human cancers, highlighting their critical role in cancer suppression.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Mammalian SWI/SNF (mSWI/SNF) complexes, also known as BAF complexes, are increasingly recognized for their roles as tumor suppressors in human cancers.
  • Understanding the complete subunit composition and mutation landscape of mSWI/SNF is crucial for elucidating their full impact on tumorigenesis.

Purpose of the Study:

  • To perform a comprehensive proteomic analysis of endogenous mSWI/SNF complexes to identify novel subunits.
  • To determine the mutation frequency of mSWI/SNF subunits across a wide range of human tumors.
  • To investigate the tissue-specific roles and prevalence of compound heterozygosity in mSWI/SNF mutations.

Main Methods:

  • Proteomic analysis of endogenous mSWI/SNF complexes to identify subunit composition.
  • Analysis of exome and whole-genome sequencing data from primary human tumors to assess mutation frequency.
  • Bioinformatic analysis to correlate subunit mutations with specific cancer types and tissues.

Main Results:

  • Identification of several new stable subunits of mSWI/SNF complexes, including BCL7A, BCL7B, BCL7C, BCL11A, BCL11B, BRD9, and SS18.
  • mSWI/SNF subunits are collectively mutated in 19.6% of human tumors across 44 studies.
  • Specific subunits show protective roles in distinct tissues, and compound heterozygosity is common in certain cancers.

Conclusions:

  • mSWI/SNF is the most frequently mutated chromatin-regulatory complex (CRC) in human cancer, with a mutation pattern similar to TP53.
  • The proper function of polymorphic BAF complexes is essential for tumor suppression.
  • These findings underscore the critical role of mSWI/SNF complexes in preventing cancer development.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...